-
2
-
-
0345714860
-
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
-
Forastiere A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
-
(2003)
N Engl J Med
, vol.349
, pp. 2091-2098
-
-
Forastiere, A.1
Goepfert, H.2
Maor, M.3
-
3
-
-
53049101141
-
-
Forastiere A, Maor M, Weber RS et al. Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx. Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. In: Proc. ASCO 2006, abs no 5517.
-
Forastiere A, Maor M, Weber RS et al. Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx. Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. In: Proc. ASCO 2006, abs no 5517.
-
-
-
-
4
-
-
0034681783
-
Chemotherapy added to loco-regional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data
-
Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to loco-regional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
-
(2000)
Lancet
, vol.355
, pp. 949-955
-
-
Pignon, J.P.1
Bourhis, J.2
Domenge, C.3
-
5
-
-
34548428839
-
Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update
-
Pignon J.P., le Mai{dotless}̂tre A., Bourhis J., et al. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69 (2007) 112-114
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
, pp. 112-114
-
-
Pignon, J.P.1
le Maître, A.2
Bourhis, J.3
-
6
-
-
0026779826
-
Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
-
Merlano M., Vitale V., Rosso R., et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327 (1992) 1115-1121
-
(1992)
N Engl J Med
, vol.327
, pp. 1115-1121
-
-
Merlano, M.1
Vitale, V.2
Rosso, R.3
-
7
-
-
9244264477
-
Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
-
Merlano M., Benasso M., Corvò R., et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88 (1996) 583-589
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 583-589
-
-
Merlano, M.1
Benasso, M.2
Corvò, R.3
-
8
-
-
0035575766
-
Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck
-
Corvò R., Benasso M., Sanguineti G., et al. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Cancer 92 (2001) 2856-2867
-
(2001)
Cancer
, vol.92
, pp. 2856-2867
-
-
Corvò, R.1
Benasso, M.2
Sanguineti, G.3
-
9
-
-
53049091219
-
-
Lefebvre J, Horiot J, Rolland F et al. Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemoradiotherapy in resectable hypopharynx and larynx cancers: EORTC protocol 24954-22950. In: Proceed. ASCO 2007, abs no LBA6016.
-
Lefebvre J, Horiot J, Rolland F et al. Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemoradiotherapy in resectable hypopharynx and larynx cancers: EORTC protocol 24954-22950. In: Proceed. ASCO 2007, abs no LBA6016.
-
-
-
-
10
-
-
0028784506
-
Interaction between cisplatin and gemcitabine in vitro and in vivo
-
Peters G.J., Bergman A.M., Ruiz van Haperen V.W.T., et al. Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 22 (1995) 72-79
-
(1995)
Semin Oncol
, vol.22
, pp. 72-79
-
-
Peters, G.J.1
Bergman, A.M.2
Ruiz van Haperen, V.W.T.3
-
11
-
-
0032441793
-
Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck
-
Hitt R., Castellano D., Hidalgo M., et al. Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck. Ann Oncol 9 (1998) 1347-1349
-
(1998)
Ann Oncol
, vol.9
, pp. 1347-1349
-
-
Hitt, R.1
Castellano, D.2
Hidalgo, M.3
-
12
-
-
0029805849
-
Gemcitabine and radiosensitization in human tumor cells
-
Shewach D.S., and Lawrence T.S. Gemcitabine and radiosensitization in human tumor cells. Invest New Drugs 14 (1996) 257-263
-
(1996)
Invest New Drugs
, vol.14
, pp. 257-263
-
-
Shewach, D.S.1
Lawrence, T.S.2
-
13
-
-
0035253713
-
Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study
-
Eisbruch A., Shewach D.S., Bradford C.R., et al. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol 19 (2001) 792-799
-
(2001)
J Clin Oncol
, vol.19
, pp. 792-799
-
-
Eisbruch, A.1
Shewach, D.S.2
Bradford, C.R.3
-
14
-
-
0035205773
-
Gemcitabine, cisplatin, and radiation for advanced, unresectable squamous cell carcinoma of the head and neck. A feasibility study
-
Benasso M., Merlano M., Sanguineti G., et al. Gemcitabine, cisplatin, and radiation for advanced, unresectable squamous cell carcinoma of the head and neck. A feasibility study. Am J Clin Oncol 24 (2001) 618-622
-
(2001)
Am J Clin Oncol
, vol.24
, pp. 618-622
-
-
Benasso, M.1
Merlano, M.2
Sanguineti, G.3
-
15
-
-
2342438685
-
Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck
-
Benasso M., Corvò R., Ponzanelli A., et al. Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck. Ann Oncol 15 (2004) 646-652
-
(2004)
Ann Oncol
, vol.15
, pp. 646-652
-
-
Benasso, M.1
Corvò, R.2
Ponzanelli, A.3
-
16
-
-
0034861302
-
Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
-
Samlowski W.E., Gundacker H., Kuebler J.P., et al. Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Invest New Drugs 19 (2001) 311-315
-
(2001)
Invest New Drugs
, vol.19
, pp. 311-315
-
-
Samlowski, W.E.1
Gundacker, H.2
Kuebler, J.P.3
-
17
-
-
0019365237
-
Reporting results of cancer treatment
-
Miller A.B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
-
(1981)
Cancer
, vol.47
, pp. 207-214
-
-
Miller, A.B.1
Hoogstraten, B.2
Staquet, M.3
-
19
-
-
0020108590
-
One-sample multiple testing procedure for phase II clinical trial
-
Fleming T.R. One-sample multiple testing procedure for phase II clinical trial. Biometrics 38 (1982) 143-151
-
(1982)
Biometrics
, vol.38
, pp. 143-151
-
-
Fleming, T.R.1
-
20
-
-
33845382806
-
Non-parametric estimation for incomplete observation
-
Kaplan E.L., and Meyer P. Non-parametric estimation for incomplete observation. J Am Stat Assoc 53 (1958) 457-474
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-474
-
-
Kaplan, E.L.1
Meyer, P.2
-
21
-
-
0029076576
-
Overview of late effects normal tissues (LENT) scoring system
-
Rubin P., Constine L.S., Fajardo L.F., et al. Overview of late effects normal tissues (LENT) scoring system. Radiotherapy & Oncology 35 (1995) 9-10
-
(1995)
Radiotherapy & Oncology
, vol.35
, pp. 9-10
-
-
Rubin, P.1
Constine, L.S.2
Fajardo, L.F.3
-
22
-
-
21144448598
-
concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14
-
Ang K.K., Harris J., Garden A.S., et al. concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14. J Clin Oncol 23 (2005) 3008-3015
-
(2005)
J Clin Oncol
, vol.23
, pp. 3008-3015
-
-
Ang, K.K.1
Harris, J.2
Garden, A.S.3
-
23
-
-
33748636873
-
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell carcinoma of the head and neck
-
Tsao A.S., Garden A.S., Kies M.S., et al. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol 24 (2006) 4163-4169
-
(2006)
J Clin Oncol
, vol.24
, pp. 4163-4169
-
-
Tsao, A.S.1
Garden, A.S.2
Kies, M.S.3
-
24
-
-
33748949062
-
Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule
-
Numico G., Russi E.G., Vitiello R., et al. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule. Int J Radiat Oncol Biol Phys 66 (2006) 731-737
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 731-737
-
-
Numico, G.1
Russi, E.G.2
Vitiello, R.3
-
25
-
-
10744224541
-
Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck
-
Aguilar-Ponce J., Granados-Garcia M., Villavicencio V., et al. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck. Ann Oncol 15 (2004) 301-306
-
(2004)
Ann Oncol
, vol.15
, pp. 301-306
-
-
Aguilar-Ponce, J.1
Granados-Garcia, M.2
Villavicencio, V.3
-
26
-
-
1642382955
-
Competing causes of death and second primary tumor in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy
-
Argiris A., Brockstein B.E., Haraf D.J., et al. Competing causes of death and second primary tumor in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 10 (2004) 1956-1962
-
(2004)
Clin Cancer Res
, vol.10
, pp. 1956-1962
-
-
Argiris, A.1
Brockstein, B.E.2
Haraf, D.J.3
|